CD8A and neoplasm: Furthermore, the proportion of Kaede Green+ CD8 T cells was not significantly different between isotype and PD-L1–treated mice, suggesting that anti–PD-L1 Abs did not result in enhanced recruitment of CD8 T cells into the tumor, at least between day 13–15 after tumor engraftment (Fig. 8 E).